INS and Polyuria: Having established the reliability of the UI for monitoring onset and development of polyuria, we evaluated its applicability to assess the therapeutic efficacy of glucose-lowering intervention with long-acting insulin for mice with constant glucose of >30 mM in weeks 4–6 after STZ treatment (insulin treatment of both mice in cage 9 and one mouse in cage 11).